Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9789571 | 0.88 | LMNA (0.57) | LMNATHRB | |
| Isobutyraldehyde SCHEMBL427264 | 0.84 | LMNA (0.67) | LMNATHRB | |
| SCHEMBL11338287 | 0.82 | LMNA (0.63) | LMNATHRB | |
| SCHEMBL11769218 | 0.82 | LMNA (0.63) | LMNATHRB | |
| SCHEMBL4293299 | 0.81 | LMNA (0.71) | LMNATHRB | |
| Acetaldehyde SCHEMBL212729 | 0.81 | LMNA (0.71) | LMNATHRB | |
| SCHEMBL5582150 | 0.80 | LMNA (0.60) | LMNATHRB | |
| SCHEMBL9192876 | 0.80 | LMNA (0.60) | LMNATHRB | |
| SCHEMBL8039396 | 0.80 | LMNA (0.60) | LMNATHRB | |
| SCHEMBL5182043 | 0.80 | LMNA (0.60) | LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8637673-B2 | Method for producing 2,2-difluoroethylamine derivatives by imine hydrogenation | BAYER CROPSCIENCE AG (DE) | 2014-01-28 | — | — | US | disclosed |
| US-20120022264-A1 | METHOD FOR PRODUCING 2,2 DIFLUOROETHYLAMINE DERIVATIVES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AG (DE) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022264-A1 | METHOD FOR PRODUCING 2,2 DIFLUOROETHYLAMINE DERIVATIVES BY IMINE HYDROGENATION | CYP2F1, AKR7A2, INF2 | LMNA 2646/4885THRB 2128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.